Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
02/2000
02/08/2000US6022694 Assay for ligands to tyrosine kinase receptors
02/08/2000US6022692 Diagnosis of cancer in humans; screening sample with nucleotide sequences associated with cancer, hybridizing, the formation of hybridization complexes is indicative of cancer potential
02/08/2000US6022546 Toxoplasma gondii antigens, the preparation thereof and the use thereof
02/08/2000US6022543 Hepatitis B surface antigen vaccine
02/08/2000US6022542 Polypeptide which serves as reagent in diagnostic kit for detecting an anti-herpesvirus antibody present in a biological sample; kaposi's sarcoma (ks) and retroperitoneal fibromatosis (rf)
02/08/2000US6022541 Immunological preparation for concurrent specific binding to spatially exposed regions of vascular permeability factor bound in-vivo to a tumor associated blood vessel
02/08/2000US6022540 Ligands that modulate differentiation of mesenchymal stem cells
02/08/2000US6022539 Injecting collagenase into a fibrous peyronie's plaque in the penis, immobilizing the penis immediately after injection for several hours, collagenase softens and/or ruptures the plaque to ameliorate erectile deviation caused by the plaque
02/08/2000US6022538 Administering adriamycin or cisplatin, and cell therapy cells modified by in vitro treatment with a cytokine and gamma irradiation at a dose to irreversibly arrest cell proliferation but not interfere with the cytotoxic activity
02/08/2000US6022536 Combined use of interleukin 10 and cyclosporin for immunosuppression therapy
02/08/2000US6022535 Administering human interleukin-3 variant or mutant proteins (muteins) fused with other colony stimulating factors, cytokines, lyphokines, interleukins, hematopoietic growth factors; treating side effects of cancer radiation therapy
02/08/2000US6022534 Lymphotactin uses
02/08/2000US6022523 Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
02/08/2000CA2271571C Improved phase separation-microencapsulated pharmaceutical compositions useful for alleviating dental disease
02/08/2000CA2004206C Method for preparing pertussis toxin toxoid
02/03/2000WO2000005586A2 Rna helicases modulating translation termination
02/03/2000WO2000005407A2 DUPLICATIONS OF HUMAN CHROMOSOME 15q24-25 AND ANXIETY DISORDERS, DIAGNOSTIC METHODS FOR THEIR DETECTION
02/03/2000WO2000005394A1 Vectors derived from baculovirus and use for transferring nucleic acids into nerve cells of vertebrates
02/03/2000WO2000005388A1 Genes of the dead box protein family, their expression products and use
02/03/2000WO2000005380A1 Regions of papilloma virus e1 helicase involved in e1 oligomerization
02/03/2000WO2000005375A1 Gbs toxin receptor
02/03/2000WO2000005374A2 Molecules associated with cell proliferation
02/03/2000WO2000005372A1 Human ion transport-like protein
02/03/2000WO2000005371A1 Keratinocyte derived interferon
02/03/2000WO2000005370A1 Orphan cytokine receptor
02/03/2000WO2000005369A2 Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesis
02/03/2000WO2000005368A1 Human calcium regulatory proteins
02/03/2000WO2000005363A1 Method for screening of modulators of calcineurin activity
02/03/2000WO2000005362A1 Mekk1(serine threonine kinases)-interacting fha (forkhead associated domain) protein 1 (mif1)
02/03/2000WO2000005361A1 Human sbpsapl gene with homology to the prosaposin family of neurotrophic factors
02/03/2000WO2000005358A1 Methods for purifying nucleic acids
02/03/2000WO2000005356A1 Methods and compositions for inhibition of angiogenesis
02/03/2000WO2000005348A1 Pneumococcal nrdg protein
02/03/2000WO2000005345A1 Human thyrotropin receptor compositions and use thereof
02/03/2000WO2000005269A1 Polymer complexes of glucuronoglucanes
02/03/2000WO2000005268A1 Hybrid human/rodent igg antibody to cd3, and methods of its construction
02/03/2000WO2000005263A2 Compounds for use in the treatment of inflammation
02/03/2000WO2000005262A1 Uses of igf-i e domain peptides
02/03/2000WO2000005260A1 Peptide analogues of pacap
02/03/2000WO2000005259A1 Secreted cysteine rich protein-6 (scrp-6)
02/03/2000WO2000005257A1 Pectic substance as a growth factor stabilizer
02/03/2000WO2000005255A2 Anti-inflammatory compounds
02/03/2000WO2000005254A2 Novel peptides for use in immunotherapy of autoimmune diseases
02/03/2000WO2000005253A2 Antagonists specific for the corticotropin-releasing factor receptor type 2 (crfr2)
02/03/2000WO2000005251A1 Aerothricin analogs, their preparation and use
02/03/2000WO2000005250A1 Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides
02/03/2000WO2000005249A2 Synthetic peptides and methods of use for autoimmune disease therapies
02/03/2000WO2000005246A1 Thioazepinone derivatives, preparation method and intermediates therefor, use as medicines and pharmaceutical compositions containing same
02/03/2000WO2000005245A2 Inhibitors of urokinase and blood vessel formation
02/03/2000WO2000005244A1 HUMAN BOMBESIN RECEPTOR SUBTYPE-3sb
02/03/2000WO2000005241A1 Angiopoietin related gene sequence scarface 2
02/03/2000WO2000005208A1 Amino-aldehyde solid support, linker therefor and methods of preparation and use thereof
02/03/2000WO2000004939A1 Dental pin
02/03/2000WO2000004937A1 Flat flexible materials
02/03/2000WO2000004929A1 Use of decreasing levels of functional transient receptor potential gene product
02/03/2000WO2000004928A1 Gene therapy method for revascularizing ischemic tissue
02/03/2000WO2000004926A2 Conjugates for treating inflammatory disorders and associated tissue damage
02/03/2000WO2000004925A1 Slow release formulations comprising anionic polysaccharide
02/03/2000WO2000004924A1 Composition and pharmaceutical dosage form for colonic drug delivery using polysaccharides
02/03/2000WO2000004923A1 Scrp-5: secreted cysteine rich protein-5
02/03/2000WO2000004917A2 USE OF HC gp-39 IN IMMUNE DISEASES
02/03/2000WO2000004915A1 Compositions and methods for the treatment or prevention of pulmonary infections
02/03/2000WO2000004913A1 Fsh and fsh variant formulations, products and methods
02/03/2000WO2000004907A1 An antilipemic formulation
02/03/2000WO2000004897A1 Bioimplant formulation
02/03/2000WO2000004891A2 Anti-ulcer composition
02/03/2000WO2000004882A1 Formulations of anionic polysaccharides
02/03/2000WO2000004877A1 Suppository formulations comprising anionic polysaccharide
02/03/2000WO2000004868A2 Libraries of polyhydroxamates and their analogs
02/03/2000WO2000004863A2 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
02/03/2000WO1999066903A3 Large porous particles emitted from an inhaler
02/03/2000WO1999065922A3 Prenyl transferase inhibitors
02/03/2000WO1999065517A3 Therapeutic compositions that produce an immune response by altering the antigen
02/03/2000WO1999064464A3 Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means
02/03/2000WO1999064450A3 Cif130 inhibits cell cycle progression
02/03/2000WO1999064448A3 Moraxella catarrhalis pilq proteins
02/03/2000WO1999063936A3 Novel therapeutic agents that modulate endothelin receptors
02/03/2000WO1999063933A3 Multivalent agonists, partial agonists and antagonists of the gaba receptors
02/03/2000WO1999063929A3 Multibinding inhibitors of microsomal triglyceride transferase protein
02/03/2000WO1999060120A3 Soluble t cell receptor
02/03/2000WO1999060119A3 Multivalent t cell receptor complexes
02/03/2000WO1999059620A9 Angiostatin receptor
02/03/2000WO1999058571A3 Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof
02/03/2000WO1999058145A3 Immunomodulators for vaccines
02/03/2000WO1999057139A3 Pth2 receptor selective compounds
02/03/2000WO1999054459A8 Nucleic acid molecules with novel chemical compositions capable of modulating gene expression
02/03/2000WO1999054352A3 Srebp-1 and srebp-2 in a phosphorylated form
02/03/2000WO1999054349A3 Dermatophagoides nucleic acid molecules, proteins and uses thereof
02/03/2000WO1999052945A9 NOVEL MOLECULES OF THE BGCKr-RELATED PROTEIN FAMILY AND USES THEREOF
02/03/2000WO1999051748A3 Fusion proteins of mycobacterium tuberculosis antigens and their uses
02/03/2000WO1999024589B1 Lysozym-analogous proteins and peptide having an anti-microbial activity, production of the same and use thereof
02/03/2000DE19847779C1 Novel receptor DNA useful for identifying apoptosis-modulating substances potentially useful for cancer chemotherapy
02/03/2000DE19835080A1 Mittel zur Behandlung des Krankheitsbildes Morbus Crohn Agents for the treatment of the disease Crohn's disease
02/03/2000DE19834591A1 Use of substances that decrease the activity of dipeptidyl peptidase IV to increase blood sugar levels, e.g. for treating hypoglycemia
02/03/2000DE19834430A1 Selbstdeletierende Vektoren für die Krebstherapie Selbstdeletierende vectors for cancer therapy
02/03/2000DE19831382A1 Humanes m¶3¶G-cap-spezifisches Kernimportrezeptorprotein mit einer neuen Domänenstruktur, dessen Herstellung und Verwendung Human m¶3¶G-cap-specific nuclear import receptor protein with a new domain tree, its preparation and use
02/03/2000CA2338561A1 Antagonists specific for the corticotropin-releasing factor receptor type 2 (crfr2)
02/03/2000CA2338524A1 Inhibitors of urokinase and blood vessel formation
02/03/2000CA2338397A1 Methods for purifying nucleic acids
02/03/2000CA2338345A1 Encapsulation of water soluble peptides
1 ... 2426 2427 2428 2429 2430 2431 2432 2433 2434 2435 2436 2437 2438 2439 2440 2441 2442 2443 2444 2445 2446 ... 3163